stars 1 stars 2 stars 3

EvlaBio AG is a biotech company, focused on the development of a therapy addressing a high unmet medical need in the cardiorenal space. Specifically, we are addressing Left Ventricular Hypertrophy (LVH) in the setting of chronic kidney disease, which affects millions of patients and for which there are limited treatment options.

EvlaBio AG Questions

Thomas Kirmeier is the Co-founder and COO of EvlaBio AG.

2 people are employed at EvlaBio AG.

Top EvlaBio AG Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users